Session Information
Free - CMES03 - Individualizing Diabetes Treatment for Improved Glycemic Control and Management of Comorbidities
Click here to go to the previous page
Management of Diabetes and Comorbidities after Failure of Oral Monotherapies
Program Code:
CMES03-3
Date:
Sunday, June 5, 2011
Time:
7:50 PM to 8:25 PM
EST
Location:
Renaissance, Pacific Ballroom DEFGH
SPEAKER
:
Richard Prately, MD, University of Vermont
Disclosure: Consultant and Research grant recipient, GlaxoSmithKline, Novartis; Consultant, Research grant recipient and Speaker, Merck & Co., Novo Nordisk, Takeda Pharmacuticals; Research grant recipient, Lilly USA, MannKind, Pfizer, Roche, sanofi-aventis U.S.
Disclosure: Consultant and Research grant recipient, GlaxoSmithKline, Novartis; Consultant, Research grant recipient and Speaker, Merck & Co., Novo Nordisk, Takeda Pharmacuticals; Research grant recipient, Lilly USA, MannKind, Pfizer, Roche, sanofi-aventis U.S.
Audio Synchronized to PowerPoint
